KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,988,322 | -22.3% | 35,415 | -0.4% | 0.02% | -19.2% |
| Q2 2023 | $7,707,066 | +127.8% | 35,541 | +90.8% | 0.03% | +116.7% |
| Q1 2023 | $3,383,590 | -58.2% | 18,628 | -54.7% | 0.01% | -58.6% |
| Q4 2022 | $8,088,923 | -56.6% | 41,165 | -50.3% | 0.03% | -21.6% |
| Q3 2022 | $18,618,178 | +54.2% | 82,774 | -13.3% | 0.04% | +68.2% |
| Q2 2022 | $12,076,449 | -2.1% | 95,462 | -1.9% | 0.02% | +22.2% |
| Q1 2022 | $12,339,601 | +26.5% | 97,320 | +30.7% | 0.02% | -28.0% |
| Q4 2021 | $9,756,000 | +8.4% | 74,471 | +1.2% | 0.02% | 0.0% |
| Q3 2021 | $9,001,000 | -44.3% | 73,582 | -48.1% | 0.02% | +8.7% |
| Q2 2021 | $16,158,000 | +89.4% | 141,746 | +99.7% | 0.02% | -11.5% |
| Q1 2021 | $8,533,000 | +59.0% | 70,975 | +34.4% | 0.03% | +52.9% |
| Q4 2020 | $5,365,000 | +36.9% | 52,809 | +4.2% | 0.02% | +21.4% |
| Q3 2020 | $3,919,000 | -65.6% | 50,683 | -50.4% | 0.01% | -36.4% |
| Q2 2020 | $11,380,000 | – | 102,092 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |